Oncology9 Oct 2011
According to the US Preventive Services Task Force, which advises the government on health prevention measures, PSA test used for the screening of prostate cancer is no longer recommended. The panel has downgraded the screening test to level “D”, i.e. the service does not offer any benefits and on the contrary, it may prove harmful. The panel has downgraded the test after reviewing increasing scientific evidence against the test. The committee found that compared to the number of prostate...
Oncology30 Sep 2011
According to a new study, which was presented at the 2011 European Multidisciplinary Cancer Congress, a higher than normal blood pressure has been found to be associated with a 10-20% higher risk of developing cancer in men, and a higher risk of dying from the disease in both men and women. The risk appears to be more for cancers of the kidney and colorectum, though it is less compared to the risk of cancer with diabetes and other vascular diseases. The study was carried out by Dr Van...
Oncology27 Sep 2011
Almost 2,500 to 5,000 pregnant women are diagnosed with cancer every year in Europe. However, most of these women either abort their pregnancies or defer their treatment till after childbirth in order to save their children from the ill effects of chemotherapy. The women who decide against abortion are advised by their gynecologists to deliver the baby as soon as it becomes viable. However, according to a new research presented today at the European Multidisciplinary Cancer Congress (EMCC) in...
Oncology25 Sep 2011
It is necessary to take biopsies at regular intervals to ensure appropriate treatment of breast cancer. This is because the breast cancer tumors have been found to change their hormonal status throughout the course of disease. This especially holds true in case of a relapse. Normally the treatment is initiated on the basis of one biopsy of the primary tumor. However, it is necessary to verify the nature of the tumor through another biopsy in case of a relapse. These are the findings of a new...
Oncology20 Sep 2011
Researchers have found Lunasin, a soy peptide to be effective in preventing metastasis of colon cancer to liver and other body parts. It was also found to potentiate the actions of Oxyplatin, a chemotherapeutic medicine, in modifying expression of proteins involved in apoptosis and metastasis. The study can be accessed online in the recent issue of “Cancer Letters.” In the study, led by Elvira de Mejia, a researcher at the University of Illinois, four groups of mice were studied: the first...
- Genetically Good Absorbers of Calcium More Prone to Develop Prostate Cancer
- Cancers of Lungs, and Head and Neck Found More in Early Morning Smokers
- New Breakthroughs in Understanding the Spread of Breast Cancer and its Treatment
- Falling Rate of Breast Cancer Deaths cannot be Attributed to Breast Screening Tests
- Higher Incidence of Stomach Cancer in Men Explained
- Diabetes Drug Linked to Bladder Cancer
- Drug to prevent the spreading of early lung cancer discovered
- Partners of cancer patients are at an increased risk of suffering from more illness themselves
- Cancer therapies increases risk of falling in Breast Cancer patients
- New Targeted Biopsy for Prostate Cancer